AI Prescription Refills Spark Debate Over Safety, Oversight, and the Future of Clinical Care

Artificial intelligence (AI) continues to reshape health care, but a new pilot program in Utah is raising important questions about how much responsibility AI should assume in patient care. The program, which was launched through a state regulatory sandbox, allows an AI chatbot developed by Doctronic to authorize prescription refills for certain chronic medications after evaluating patient responses and pharmacy records. Although supporters argue the technology could improve access to care and reduce administrative burden, health care professionals and regulators caution that prescription renewal represents a critical clinical decision rather than a simple administrative task.^1,2

Balancing Efficiency With Clinical Oversight

Utah's pilot permits eligible patients to request prescription refills through an AI-powered chatbot that verifies prescription history and screens for potential concerns before either approving the refill or referring the patient to a physician. Initially, physicians reviewed every refill decision, but the program is expected to transition toward greater autonomy over time.¹

The initiative has drawn scrutiny because current federal and state laws generally reserve prescribing authority for licensed medical professionals. Experts have questioned whether autonomous AI systems should undergo regulatory review comparable to licensed health care professionals or medical devices before assuming responsibilities that directly influence patient care.^1,2

According to Nilesh Desai, MBA, BS, RPh, CPPS, CPEL, chief pharmacy officer at the University of Miami Miller School of Medicine, AI has the potential to meaningfully improve refill management, but it should function as clinical decision support rather than an independent prescriber.

"AI-assisted refill management has significant potential to improve operational efficiency, patient access, medication adherence, and ongoing therapy monitoring," Desai said in an interview with Pharmacy Times. "However, AI should be implemented as a clinical decision support tool that augments professional practice rather than as an autonomous replacement for clinical judgment."

Prescription Refills Are More Than Administrative Tasks

Although prescription renewals may appear routine, they often serve as an opportunity to reassess whether therapy remains appropriate. Changes in renal function, newly prescribed medications, adverse effects, or disease progression may all require therapy modification before another prescription can be authorized.^1,2

Desai emphasized that refill authorization represents "an important clinical checkpoint to ensure that therapy remains appropriate, safe, and effective for the patient."

He noted that AI can efficiently gather patient information, evaluate protocol compliance, identify exceptions, and support decision-making, but decisions to continue, modify, or discontinue therapy should remain under the oversight of qualified health care professionals.

Medical organizations have expressed similar concerns, warning that AI may not fully recognize complex clinical changes that occur between patient visits or identify situations requiring additional evaluation before medication continuation.^1,2

Opportunities for Pharmacy Practice

Despite ongoing regulatory concerns, pharmacy leaders recognize significant opportunities for AI to improve medication management workflows.

Desai explained that AI could reduce manual workload while allowing pharmacists and pharmacy technicians to devote more time to higher-value clinical responsibilities, particularly as workforce shortages continue across health systems.

"Health care organizations should maximize the use of technology to enhance capacity and optimize resource utilization," Desai said. "[With] that said, efficiency gains must never come at the expense of patient safety or clinical quality."

As AI becomes increasingly integrated into clinical practice, pharmacists may play a critical role in validating AI-generated recommendations, identifying medication-related risks, and ensuring patients continue to receive individualized care.

Although Utah's pilot may represent an important milestone in AI-enabled health care, experts agree that broader adoption will require stronger evidence demonstrating safety, effectiveness, and appropriate regulatory oversight before autonomous prescribing becomes standard practice.^1,2

REFERENCES

1. Perrone M. Is AI ready to take over your prescriptions? Doctors are wary of Utah’s automated refill program. The Associated Press. July 6, 2026. Accessed July 10, 2026. https://apnews.com/article/ai-prescription-refill-utah-doctronic-fda-technology-cf94ce370c05f686e8792be8671a2ef0

2. Gerke S, Parikh RB, Cohen IG. Utah's Prescription-Renewal Pilot Program - Autonomous AI Managing Patient Care. N Engl J Med. 2026;394(16):1561-1563. doi:10.1056/NEJMp2601148